US Patent Issued to NOVOHEART INTERNATIONAL on April 22 for "Ex vivo methods of screening for, and characterizing, cardiac therapeutics using preloaded cardiac tissues" (Chinese, American Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,282,013, issued on April 22, was assigned to NOVOHEART INTERNATIONAL Ltd. (Kowloon, Hong Kong).

"Ex vivo methods of screening for, and characterizing, cardiac therapeutics using preloaded cardiac tissues" was invented by Ronald A. Li (Hong Kong) and Kevin D. Costa (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods and materials for assaying known and candidate therapeutics for inotropic cardiac effects in one or more in vitro assay formats comprising preloaded cardiac tissues and/or organoids."

The patent was filed on June 18, 2019, under Application No. 17/254,264.

*For further information, including images, charts and table...